Global CT Contrast Media Market Research Report 2021

1 CT Contrast Media Market Overview

• 1.1 Product Overview and Scope of CT Contrast Media
• 1.2 CT Contrast Media Segment by Type
  • 1.2.1 Global CT Contrast Media Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Iohexol
  • 1.2.3 Iodixanol
  • 1.2.4 Iopamidol
  • 1.2.5 Ioversol
  • 1.2.6 Others
• 1.3 CT Contrast Media Segment by Application
  • 1.3.1 Global CT Contrast Media Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
• 1.4 Global CT Contrast Media Market Size Estimates and Forecasts
  • 1.4.1 Global CT Contrast Media Revenue 2016-2027
  • 1.4.2 Global CT Contrast Media Sales 2016-2027
  • 1.4.3 CT Contrast Media Market Size by Region: 2016 Versus 2021 Versus 2027

2 CT Contrast Media Market Competition by Manufacturers

• 2.1 Global CT Contrast Media Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global CT Contrast Media Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global CT Contrast Media Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers CT Contrast Media Manufacturing Sites, Area Served, Product Type
• 2.5 CT Contrast Media Market Competitive Situation and Trends
  • 2.5.1 CT Contrast Media Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest CT Contrast Media Players Market Share by Revenue
  • 2.5.3 Global CT Contrast Media Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 CT Contrast Media Retrospective Market Scenario by Region

• 3.1 Global CT Contrast Media Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.2 Global CT Contrast Media Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.3 North America CT Contrast Media Market Facts & Figures by Country
  • 3.3.1 North America CT Contrast Media Sales by Country
  • 3.3.2 North America CT Contrast Media Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
• 3.4 Europe CT Contrast Media Market Facts & Figures by Country
  • 3.4.1 Europe CT Contrast Media Sales by Country
  • 3.4.2 Europe CT Contrast Media Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific CT Contrast Media Market Facts & Figures by Region
  • 3.5.1 Asia Pacific CT Contrast Media Sales by Region
  • 3.5.2 Asia Pacific CT Contrast Media Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 China Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
• 3.6 Latin America CT Contrast Media Market Facts & Figures by Country
  • 3.6.1 Latin America CT Contrast Media Sales by Country
  • 3.6.2 Latin America CT Contrast Media Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
  • 3.6.6 Colombia
• 3.7 Middle East and Africa CT Contrast Media Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa CT Contrast Media Sales by Country
  • 3.7.2 Middle East and Africa CT Contrast Media Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global CT Contrast Media Historic Market Analysis by Type

• 4.1 Global CT Contrast Media Sales Market Share by Type (2016-2021)
• 4.2 Global CT Contrast Media Revenue Market Share by Type (2016-2021)
• 4.3 Global CT Contrast Media Price by Type (2016-2021)

5 Global CT Contrast Media Historic Market Analysis by Application

• 5.1 Global CT Contrast Media Sales Market Share by Application (2016-2021)
• 5.2 Global CT Contrast Media Revenue Market Share by Application (2016-2021)
• 5.3 Global CT Contrast Media Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 GE Healthcare
  • 6.1.1 GE Healthcare Corporation Information
  • 6.1.2 GE Healthcare Description and Business Overview
  • 6.1.3 GE Healthcare CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 GE Healthcare CT Contrast Media Product Portfolio
  • 6.1.5 GE Healthcare Recent Developments/Updates
• 6.2 Bayer
  • 6.2.1 Bayer Corporation Information
  • 6.2.2 Bayer Description and Business Overview
  • 6.2.3 Bayer CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Bayer CT Contrast Media Product Portfolio
  • 6.2.5 Bayer Recent Developments/Updates
• 6.3 Bracco Imaging
  • 6.3.1 Bracco Imaging Corporation Information
  • 6.3.2 Bracco Imaging Description and Business Overview
  • 6.3.3 Bracco Imaging CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Bracco Imaging CT Contrast Media Product Portfolio
  • 6.3.5 Bracco Imaging Recent Developments/Updates
• 6.4 Guerbet Group
  • 6.4.1 Guerbet Group Corporation Information
  • 6.4.2 Guerbet Group Description and Business Overview
  • 6.4.3 Guerbet Group CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Guerbet Group CT Contrast Media Product Portfolio
  • 6.4.5 Guerbet Group Recent Developments/Updates
• 6.5 Hengrui Medicine
  • 6.5.1 Hengrui Medicine Corporation Information
  • 6.5.2 Hengrui Medicine Description and Business Overview
  • 6.5.3 Hengrui Medicine CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Hengrui Medicine CT Contrast Media Product Portfolio
  • 6.5.5 Hengrui Medicine Recent Developments/Updates
• 6.6 Lantheus
  • 6.6.1 Lantheus Corporation Information
  • 6.6.2 Lantheus Description and Business Overview
  • 6.6.3 Lantheus CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Lantheus CT Contrast Media Product Portfolio
  • 6.6.5 Lantheus Recent Developments/Updates
• 6.7 YRPG
  • 6.6.1 YRPG Corporation Information
  • 6.6.2 YRPG Description and Business Overview
  • 6.6.3 YRPG CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 YRPG CT Contrast Media Product Portfolio
  • 6.7.5 YRPG Recent Developments/Updates
• 6.8 BeiLu Pharma
  • 6.8.1 BeiLu Pharma Corporation Information
  • 6.8.2 BeiLu Pharma Description and Business Overview
  • 6.8.3 BeiLu Pharma CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 BeiLu Pharma CT Contrast Media Product Portfolio
  • 6.8.5 BeiLu Pharma Recent Developments/Updates
• 6.9 Sanochemia
  • 6.9.1 Sanochemia Corporation Information
  • 6.9.2 Sanochemia Description and Business Overview
  • 6.9.3 Sanochemia CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Sanochemia CT Contrast Media Product Portfolio
  • 6.9.5 Sanochemia Recent Developments/Updates
• 6.10 Tyco Healthcare
  • 6.10.1 Tyco Healthcare Corporation Information
  • 6.10.2 Tyco Healthcare Description and Business Overview
  • 6.10.3 Tyco Healthcare CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Tyco Healthcare CT Contrast Media Product Portfolio
  • 6.10.5 Tyco Healthcare Recent Developments/Updates
• 6.11 Imax
  • 6.11.1 Imax Corporation Information
  • 6.11.2 Imax CT Contrast Media Description and Business Overview
  • 6.11.3 Imax CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Imax CT Contrast Media Product Portfolio
  • 6.11.5 Imax Recent Developments/Updates
• 6.12 Grupo Juste
  • 6.12.1 Grupo Juste Corporation Information
  • 6.12.2 Grupo Juste CT Contrast Media Description and Business Overview
  • 6.12.3 Grupo Juste CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Grupo Juste CT Contrast Media Product Portfolio
  • 6.12.5 Grupo Juste Recent Developments/Updates
• 6.13 Daiichi Sankyo
  • 6.13.1 Daiichi Sankyo Corporation Information
  • 6.13.2 Daiichi Sankyo CT Contrast Media Description and Business Overview
  • 6.13.3 Daiichi Sankyo CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Daiichi Sankyo CT Contrast Media Product Portfolio
  • 6.13.5 Daiichi Sankyo Recent Developments/Updates
• 6.14 Takeda
  • 6.14.1 Takeda Corporation Information
  • 6.14.2 Takeda CT Contrast Media Description and Business Overview
  • 6.14.3 Takeda CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Takeda CT Contrast Media Product Portfolio
  • 6.14.5 Takeda Recent Developments/Updates
• 6.15 Fuji Pharma
  • 6.15.1 Fuji Pharma Corporation Information
  • 6.15.2 Fuji Pharma CT Contrast Media Description and Business Overview
  • 6.15.3 Fuji Pharma CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Fuji Pharma CT Contrast Media Product Portfolio
  • 6.15.5 Fuji Pharma Recent Developments/Updates
• 6.16 Towaseiyaku
  • 6.16.1 Towaseiyaku Corporation Information
  • 6.16.2 Towaseiyaku CT Contrast Media Description and Business Overview
  • 6.16.3 Towaseiyaku CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Towaseiyaku CT Contrast Media Product Portfolio
  • 6.16.5 Towaseiyaku Recent Developments/Updates
• 6.17 Hikari Pharmaceutical
  • 6.17.1 Hikari Pharmaceutical Corporation Information
  • 6.17.2 Hikari Pharmaceutical CT Contrast Media Description and Business Overview
  • 6.17.3 Hikari Pharmaceutical CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 Hikari Pharmaceutical CT Contrast Media Product Portfolio
  • 6.17.5 Hikari Pharmaceutical Recent Developments/Updates
• 6.18 Consentis Diagnostics GmbH
  • 6.18.1 Consentis Diagnostics GmbH Corporation Information
  • 6.18.2 Consentis Diagnostics GmbH CT Contrast Media Description and Business Overview
  • 6.18.3 Consentis Diagnostics GmbH CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.18.4 Consentis Diagnostics GmbH CT Contrast Media Product Portfolio
  • 6.18.5 Consentis Diagnostics GmbH Recent Developments/Updates
• 6.19 T2Pharma
  • 6.19.1 T2Pharma Corporation Information
  • 6.19.2 T2Pharma CT Contrast Media Description and Business Overview
  • 6.19.3 T2Pharma CT Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.19.4 T2Pharma CT Contrast Media Product Portfolio
  • 6.19.5 T2Pharma Recent Developments/Updates

7 CT Contrast Media Manufacturing Cost Analysis

• 7.1 CT Contrast Media Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of CT Contrast Media
• 7.4 CT Contrast Media Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 CT Contrast Media Distributors List
• 8.3 CT Contrast Media Customers

9 CT Contrast Media Market Dynamics

• 9.1 CT Contrast Media Industry Trends
• 9.2 CT Contrast Media Growth Drivers
• 9.3 CT Contrast Media Market Challenges
• 9.4 CT Contrast Media Market Restraints

10 Global Market Forecast

• 10.1 CT Contrast Media Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of CT Contrast Media by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of CT Contrast Media by Type (2022-2027)
• 10.2 CT Contrast Media Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of CT Contrast Media by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of CT Contrast Media by Application (2022-2027)
• 10.3 CT Contrast Media Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of CT Contrast Media by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of CT Contrast Media by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List